Genistein and cancer: Current status, challenges, and future directions

Advances in Nutrition

Volumn 6, Issue 4, 2015, Pages 408-419

  Spagnuolo, Carmela ^a   Russo, Gian Luigi ^a   Orhan, Ilkay Erdogan ^b   Habtemariam, Solomon ^c   Daglia, Maria ^d   Sureda, Antoni ^e   Nabavi, Seyed Fazel ^f   Devi, Kasi Pandima ^g   Loizzo, Monica Rosa ^h   Tundis, Rosa ^h   Nabavi, Seyed Mohammad ^f  

^a CNR   (Italy)

^b GAZI UNIVERSITY   (Turkey)

^c UNIVERSITY OF GREENWICH   (United Kingdom)

^d UNIVERSITY OF PAVIA   (Italy)

^e UNIVERSITAT DE LES ILLES BALEARS   (Spain)

^f BAQIYATALLAH UNIVERSITY OF MEDICAL SCIENCES   (Iran)

^g ALAGAPPA UNIVERSITY   (India)

^h UNIVERSITY OF CALABRIA   (Italy)

Author keywords

Bioavailability; Cancer; Genistein; Safety; Source

Indexed keywords

ANTINEOPLASTIC AGENT; CASPASE; CASPASE INHIBITOR; GENISTEIN; PLANT MEDICINAL PRODUCT;

ANIMAL; APOPTOSIS; BIOAVAILABILITY; CELL CYCLE; CHEMOPROPHYLAXIS; DRUG EFFECTS; DRUG POTENTIATION; FABACEAE; FEMALE; HUMAN; MALE; MOUSE; NEOPLASM METASTASIS; NEOPLASMS; NEOVASCULARIZATION, PATHOLOGIC; SOY FOOD; SOYBEAN;

ANIMALS; ANTINEOPLASTIC AGENTS; APOPTOSIS; BIOLOGICAL AVAILABILITY; CASPASE INHIBITORS; CASPASES; CELL CYCLE; CHEMOPREVENTION; DRUG SYNERGISM; FABACEAE; FEMALE; GENISTEIN; HUMANS; MALE; MICE; NEOPLASM METASTASIS; NEOPLASMS; NEOVASCULARIZATION, PATHOLOGIC; PHYTOCHEMICALS; SOY FOODS; SOYBEANS;

EID: 84943242811     PISSN: 21618313     EISSN: 21565376     Source Type: Journal    
DOI: 10.3945/an.114.008052     Document Type: Article

References (174)

1. Ferlay J, Soerjomataram I, Ervik M, Dikshit R, Eser S, Mathers C, Rebelo M, Parkin D, Forman D, Bray F. GLOBOCAN 2012 version 1. 0: cancer incidence and mortality worldwide. IARC CancerBase Vol. 11. Lyon (France): International Agency for Research on Cancer; 2013. [cited 2014 Nov 13]. Available from: http://globocan.iarc.fr.
2. Bray F, Ren JS, Masuyer E, Ferlay J. Global estimates of cancer prevalence for 27 sites in the adult population in 2008. Int J Cancer 2013;132:1133-45.
3. Jemal A, Bray F, Center MM, Ferlay J, Ward E, Forman D. Global can- cer statistics. CA Cancer J Clin 2011;61:69-90.
4. World Health Organization. The World Health Organization's fight against cancer: strategies that prevent, cure and care. Geneva (Switzer- land): WHO Press; 2007.
5. Kris-Etherton PM, Hecker KD, Bonanome A, Coval SM, Binkoski AE, Hilpert KF, Griel AE, Etherton TD. Bioactive compounds in foods: their role in the prevention of cardiovascular disease and cancer. Am J Med 2002;113:71S-88S.
6. Giacosa A,Barale R,Bavaresco L,Gatenby P,Gerbi V,Janssens J, Johnston B, Kas K, La Vecchia C, Mainguet P, et al. Cancer prevention in Europe: the Mediterranean diet as a protective choice. Eur J Cancer Prev 2013;22:90-5.
7. Sung B, Prasad S, Yadav VR, Lavasanifar A, Aggarwal BB. Cancer and diet: how are they related? Free Radic Res 2011;45:864-79.
8. Martínez ME, Marshall JR, Giovannucci E. Diet and cancer preven- tion: the roles of observation and experimentation. Nat Rev Cancer 2008;8:694-703.
9. Le Marchand L, Kolonel LN, Wilkens LR, Myers BC, Hirohata T. An- imal fat consumption and prostate cancer: a prospective study in Ha- waii. Epidemiology 1994;5:276-82.
10. Giacosa A, Franceschi S, La Vecchia C, Favero A, Andreatta R. Energy intake, overweight, physical exercise and colorectal cancer risk. Eur J Cancer Prev 1999;8:S53-60.
11. Chen WY, Rosner B, Hankinson SE, Colditz GA, Willett WC. Moder- ate alcohol consumption during adult life, drinking patterns, and breast cancer risk. JAMA 2011;306:1884-90.
12. Pelucchi C, Tramacere I, Boffetta P, Negri E, Vecchia CL. Alcohol con- sumption and cancer risk. Nutr Cancer 2011;63:983-90.
13. Soobrattee MA, Bahorun T, Aruoma OI. Chemopreventive actions of polyphenolic compounds in cancer. Biofactors 2006;27:19-35.
14. Liu RH. Potential synergy of phytochemicals in cancer prevention: mechanism of action. J Nutr 2004;134(Suppl):3479S-85S.
15. Messina M, Barnes S, Setchell KD. Phyto-oestrogens and breast can- cer. Lancet 1997;350:971-2.
16. Surh Y-J. Cancer chemoprevention with dietary phytochemicals. Nat Rev Cancer 2003;3:768-80.
17. Rajendran P, Ho E, Williams DE, Dashwood RH. Dietary phytochem- icals, HDAC inhibition, and DNA damage/repair defects in cancer cells. Clin Epigenetics 2011;3:4.
18. Nabavi SF, Nabavi SM, Setzer W, Nabavi SA, Nabavi SA, Ebrahimzadeh MA. Antioxidant and antihemolytic activity of lipid-soluble bioactive sub- stances in avocado fruits. Fruits 2013;68:185-93.
19. Nabavi SF, Nabavi SM, Habtemariam S, Moghaddam AH, Sureda A, Jafari M, Latifi AM. Hepatoprotective effect of gallic acid isolated from Peltiphyllum peltatum against sodium fluoride-induced oxida- tive stress. Ind Crops Prod 2013;44:50-5.
20. Stoner GD, Mukhtar H. Polyphenols as cancer chemopreventive agents. J Cell Biochem Suppl 1995;22:169-80.
21. Amtmann E, Zöller M, Wesch H, Schilling G. Antitumoral activity of a sulphur-containing platinum complex with an acidic pH optimum. Cancer Chemother Pharmacol 2001;47:461-6.
22. Gould MN. Cancer chemoprevention and therapy by monoterpenes. Environ Health Perspect 1997;105:977-9.
23. Fang MZ, Wang Y, Ai N, Hou Z, Sun Y, Lu H, Welsh W, Yang CS. Tea polyphenol (2)-epigallocatechin-3-gallate inhibits DNA methyltrans- ferase and reactivates methylation-silenced genes in cancer cell lines. Cancer Res 2003;63:7563-70.
24. Piyanuch R, Sukhthankar M, Wandee G, Baek SJ. Berberine, a natural isoquinoline alkaloid, induces NAG-1 and ATF3 expression in human colorectal cancer cells. Cancer Lett 2007;258:230-40.
25. Howes MJR, Simmonds MS. The role of phytochemicals as micronutrients in health and disease. Curr Opin Clin Nutr Metab Care 2014;17:558-66.
26. Nabavi SM, Nabavi SF, Eslami S, Moghaddam AH. In vivo protective effects of quercetin against sodium fluoride-induced oxidative stress in the hepatic tissue. Food Chem 2012;132:931-5.
27. Arts IC, Hollman PC. Polyphenols and disease risk in epidemiologic studies. Am J Clin Nutr 2005;81(Suppl):317S-25S.
28. Khan N, Mukhtar H. Multitargeted therapy of cancer by green tea polyphenols. Cancer Lett 2008;269:269-80.
29. Daglia M. Polyphenols as antimicrobial agents. Curr Opin Biotechnol 2012;23:174-81.
30. Daglia M, Di Lorenzo A, Nabavi SF, Talas ZS, Nabavi SM. Polyphe- nols: well beyond the antioxidant capacity: gallic acid and related compounds as neuroprotective agents: you are what you eat! Curr Pharm Biotechnol 2014;15:362-72.
31. Jacob V, Hagai T, Soliman K. Structure-activity relationships of flavo- noids. Curr Org Chem 2011;15:2641-57.
32. Jaganath IB, Crozier A. Dietary flavonoids and phenolic compounds. In: Fraga CG, editor. Plant phenolics and human health: biochemistry, nutrition, and pharmacology. Hoboken (NJ): Wiley. 2010. p. 1-49.
33. Preedy VR. Isoflavones: chemistry, analysis, function and effects. Royal Society of Chemistry. Cambridge (United Kingdom); 2012.
34. Banerjee S, Li Y, Wang Z, Sarkar FH. Multi-targeted therapy of cancer by genistein. Cancer Lett 2008;269:226-42.
35. Polkowski K, Mazurek AP. Biological properties of genistein: a review of in vitro and in vivo data. Acta Pol Pharm 2000;57:135-55.
36. Klinge CM. Estrogen receptor interaction with co-activators and co- repressors. Steroids 2000;65:227-51.
37. Kurzer MS. Hormonal effects of soy in premenopausal women and men. J Nutr 2002;132(Suppl):570S-3S.
38. Yoon K, Kwack SJ, Kim HS, Lee BM. Estrogenic endocrine-disrupting chemicals: molecular mechanisms of actions on putative human dis- eases. J Toxicol Environ Health B Crit Rev 2014;17:127-74.
39. Kuiper GG, Lemmen JG, Carlsson B, Corton JC, Safe SH, van der Saag PT, van der Burg B, Gustafsson JA. Interaction of estrogenic chemicals and phytoestrogens with estrogen receptor b. Endocrinology 1998; 139:4252-63.
40. Chang YC, Nair MG, Santell RC, Helferich WG. Microwave-mediated synthesis of anticarcinogenic isoflavones from soybeans. J Agric Food Chem 1994;42:1869-71.
41. Kochs G, Grisebach H. Enzymic synthesis of isoflavones. Eur J Bio- chem 1986;155:311-8.
42. Katsuyama Y, Miyahisa I, Funa N, Horinouchi S. One-pot synthesis of genistein from tyrosine by coincubation of genetically engineered Escherichia coli and Saccharomyces cerevisiae cells. Appl Microbiol Biotechnol 2007;73:1143-9.
43. Yu O, Jung W, Shi J, Croes RA, Fader GM, McGonigle B, Odell JT. Production of the isoflavones genistein and daidzein in non-legume dicot and monocot tissues. Plant Physiol 2000;124:781-94.
44. Meng Q-H, Wähälä K, Adlercreutz H, Tikkanen MJ. Antiproliferative efficacy of lipophilic soy isoflavone phytoestrogens delivered by low density lipoprotein particles into cultured U937 cells. Life Sci 1999; 65:1695-705.
45. Somjen D, Amir-Zaltsman Y, Gayer B, Kulik T, Knoll E, Stern N, Lu LJ, Toldo L, Kohen F. 6-Carboxymethyl genistein: a novel selective oestrogen receptor modulator (SERM) with unique, differential effects on the vasculature, bone and uterus. J Endocrinol 2002;173:415-27.
46. Matsumoto T, Kobayashi T, Kikuchi T, Honda T, Kamata K. Effects of dual-action genistein derivatives on relaxation in rat aorta. J Smooth Muscle Res 2005;41:23-33.
47. Zhang LN, Xiao ZP, Ding H, Ge HM, Xu C, Zhu HL, Tan RX. Synthe- sis and cytotoxic evaluation of novel 7-o-modified genistein deriva- tives. Chem Biodivers 2007;4:248-55.
48. Shimoda K, Kobayashi T, Akagi M, Hamada H, Hamada H. Synthesis of oligosaccharides of genistein and quercetin as potential anti- inflammatory agents. Chem Lett 2008;37:876-7.
49. Kgomotso T, Chiu F, Ng K. Genistein-and daidzein 7-O-b-D-glucur- onic acid retain the ability to inhibit copper-mediated lipid oxidation of low density lipoprotein. Mol Nutr Food Res 2008;52:1457-66.
50. Fu XH, Wang L, Zhao H, Xiang H-L, Cao JG. Synthesis of genistein derivatives and determination of their protective effects against vascu- lar endothelial cell damages caused by hydrogen peroxide. Bioorg Med Chem Lett 2008;18:513-7.
51. Zheng X, Yao X, Liu Y, Zheng Z, Cao J, Liao D. Synthesis and cytotoxic activity of genistein derivatives. Med Chem Res 2010;19:1296-306.
52. Maniewska J, Grynkiewicz G, Szeja W, Hendrich A. Interaction of genistein benzyl derivatives with lipid bilayers-fluorescence spectro- scopic and calorimetric study. Bioorg Med Chem 2009;17:2592-7.
53. Choi JN, Kim D,Choi HK,Yoo KM,Kim J,LeeCH.29-Hydroxylation of genistein enhanced antioxidant and antiproliferative activities in Mcf-7 human breast cancer cells. J Microbiol Biotechnol 2009;19:1348-54.
54. Zengin G. Synthesis, antimicrobial activity, and structure-activity re- lationships of eugenol, menthol, and genistein esters. Chem Nat Compd 2011;47:550-5.
55. Fan YE, Li J, Liu R, Ye ZG, Hu JN, Deng ZY, Peng Y. Oral bioavaila- bility of novel genistein sulfonates and their pre-clinical pharmacoki- netics. Lat Am J Pharm 2011;30:1582-9.
56. Hyz K, Kawecki R, Misior A, Bocian W, Bednarek EB, Sitkowski J, Kozerski L. Genistein binding mode to doubly nicked dumbbell DNA: dynamic and diffusion ordered NMR study. J Med Chem 2011;54:8386-93.
57. Li W, Jia HY, He XH, Shi WG, Zhong BH. Novel phenoxyalkylcarbox- ylic acid derivatives as hypolipidaemic agents. J Enzyme Inhib Med Chem 2012;27:311-8.
58. Qiang X, Sang Z, Yuan W, Li Y, Liu Q, Bai P, Shi Y, Ang W, Tan Z, Deng Y. Design, synthesis and evaluation of genistein-O-alkylbenzyl- amines as potential multifunctional agents for the treatment of Alz- heimer's disease. Eur J Med Chem 2014;76:314-31.
59. Bhagwat S, Haytowitz DB, Holden JM. USDA database for the isoflavone content of selected foods. Release 2.0. Bethesda (MD): USDA; 2008.
60. Messina M, Nagata C, Wu AH. Estimated Asian adult soy protein and isoflavone intakes. Nutr Cancer 2006;55:1-12.
61. van Erp-Baart M-AJ, Brants HA, Kiely M, Mulligan A, Turrini A, Sermoneta C, Kilkkinen A, Valsta LM. Isoflavone intake in four different European countries: the VENUS approach. Br J Nutr 2003;89:S25-30.
62. Liggins J, Bluck L, Runswick S, Atkinson C, Coward W, Bingham S. Daidzein and genistein contents of vegetables. Br J Nutr 2000;84:717-25.
63. Liggins J, Bluck LJ, Runswick S, Atkinson C, Coward WA, Bingham SA. Daidzein and genistein content of fruits and nuts. J Nutr Biochem 2000;11:326-31.
64. Ahmad S, Pathak D. Nutritional changes in soybean during germina- tion. J Food Sci Technol 2000;37:665-6.
65. KimWJ, Lee HY,Won MH, Yoo SH. Germination effect of soybean on its contents of isoflavones and oligosaccharides. Food Sci Biotechnol 2005;14:498-502.
66. Paucar-Menacho LM, Berhow MA, Mandarino JMG, Chang YK, Mejia EG. Effect of time and temperature on bioactive compounds in germi- nated Brazilian soybean cultivar BRS 258. Food Res Int 2010;43:1856-65.
67. Shi H, Nam PK, Ma Y. Comprehensive profiling of isoflavones, phy- tosterols, tocopherols, minerals, crude protein, lipid, and sugar during soybean (Glycine max) germination. J Agric Food Chem 2010;58: 4970-6.
68. Yuan JP, Liu YB, Peng J, Wang JH, Liu X. Changes of isoflavone profile in the hypocotyls and cotyledons of soybeans during dry heating and germination. J Agric Food Chem 2009;57:9002-10.
69. Quinhone A Jr., Ida E. Profile of the contents of different forms of soybean isoflavones and the effect of germination time on these com- pounds and the physical parameters in soybean sprouts. Food Chem 2015;166:173-8.
70. Lee SY, Lee S, Lee S, Oh JY, Jeon EJ, Ryu HS, Lee CH. Primary and secondary metabolite profiling of doenjang, a fermented soybean paste during industrial processing. Food Chem 2014;165:157-66.
71. Sohn SI, Kim YH, Kim SL, Lee JY, Oh YJ, Chung JH, Lee KR. Genis- tein production in rice seed via transformation with soybean IFS genes. Plant Sci 2014;217-218:27-35.
72. Steensma A, Faassen-Peters MA, Noteborn HP, Rietjens IM. Bioavail- ability of genistein and its glycoside genistin as measured in the portal vein of freely moving unanesthetized rats. J Agric Food Chem 2006; 54:8006-12.
73. Kwon SH, Kang MJ, Huh JS, Ha KW, Lee JR, Lee SK, Lee BS, Han IH, Lee MS, Lee MW, et al. Comparison of oral bioavailability of genistein and genistin in rats. Int J Pharm 2007;337:148-54.
74. Motlekar N, Khan MA, Youan BBC. Preparation and characterization of genistein containing poly (ethylene glycol) microparticles. J Appl Polym Sci 2006;101:2070-8.
75. Huang AS, Hsieh OAL, Chang SS. Characterization of the nonvolatile minor constituents responsible for the objectionable taste of defatted soybean flour. J Food Sci 1982;47:19-23.
76. Kobayashi S, Shinohara M, Nagai T, Konishi Y. Transport mechanisms for soy isoflavones and microbial metabolites dihydrogenistein and di- hydrodaidzein across monolayers and membranes. Biosci Biotechnol Biochem 2013;77:2210-7.
77. Schoefer L, Mohan R, Braune A, Birringer M, Blaut M. Anaerobic C- ring cleavage of genistein and daidzein by Eubacterium ramulus. FEMS Microbiol Lett 2002;208:197-202.
78. Tamura M, Ohnishi-Kameyama M, Nakagawa H, Tsushida T. Dihydrogenistein-producing bacterium TM-40 isolated from human feces. Food Sci Technol Res 2007;13:129-32.
79. Shelnutt SR, Cimino CO, Wiggins PA, Ronis MJ, Badger TM. Pharma- cokinetics of the glucuronide and sulfate conjugates of genistein and daidzein in men and women after consumption of a soy beverage. Am J Clin Nutr 2002;76:588-94.
80. Hosoda K, Furuta T, Yokokawa A, Ishii K. Identification and quanti- fication of daidzein-7-glucuronide-49-sulfate, genistein-7-glucuronide-49- sulfate and genistein-49,7-diglucuronide as major metabolites in human plasma after administration of kinako. Anal Bioanal Chem 2010;397: 1563-72.
81. Sfakianos J, Coward L, Kirk M, Barnes S. Intestinal uptake and biliary excretion of the isoflavone genistein in rats. J Nutr 1997;127:1260-8.
82. Sirtori CR. Risks and benefits of soy phytoestrogens in cardiovascular diseases, cancer, climacteric symptoms and osteoporosis. Drug Saf 2001;24:665-82.
83. Bloedon LT, Jeffcoat AR, Lopaczynski W, Schell MJ, Black TM, DixKJ,ThomasBF,AlbrightC,BusbyMG,CrowellJA,etal. Safety and pharmacokinetics of purified soy isoflavones: single- dose administration to postmenopausal women. Am J Clin Nutr 2002;76:1126-37.
84. Klein CB, King AA. Genistein genotoxicity: critical considerations of in vitro exposure dose. Toxicol Appl Pharmacol 2007;224:1-11.
85. Touny LHE, Banerjee PP. Identification of both Myt-1 and Wee-1 as necessary mediators of the p21-independent inactivation of the Cdc-2/cyclin B1 complex and growth inhibition of TRAMP cancer cells by genistein. Prostate 2006;66:1542-55.
86. Snyder RD, Gillies PJ. Reduction of genistein clastogenicity in Chinese hamster V79 cells by daidzein and other flavonoids. Food Chem Tox- icol 2003;41:1291-8.
87. Ramos S. Effects of dietary flavonoids on apoptotic pathways related to cancer chemoprevention. J Nutr Biochem 2007;18:427-42.
88. Michael McClain R, Wolz E, Davidovich A, Bausch J. Genetic toxicity studies with genistein. Food Chem Toxicol 2006;44:42-55.
89. Jefferson WN, Williams CJ. Circulating levels of genistein in the neo- nate, apart from dose and route, predict future adverse female repro- ductive outcomes. Reprod Toxicol 2011;31:272-9.
90. Rozman KK, Bhatia J, Calafat AM, Chambers C, Culty M, Etzel RA, Flaws JA, Hansen DK, Hoyer PB, Jeffery EH, et al. NTP-CERHR expert panel report on the reproductive and developmental toxicity of genis- tein. Birth Defects Res B Dev Reprod Toxicol 2006;77:485-638.
91. Franke AA, Custer LJ, Wang W, Shi CY. HPLC analysis of isoflavo- noids and other phenolic agents from foods and from human fluids. Proc Soc Exp Biol Med 1998;217:263-73.
92. Cao Y, Calafat AM, Doerge DR, Umbach DM, Bernbaum JC, Twaddle NC, Ye X, Rogan WJ. Isoflavones in urine, saliva, and blood of infants: data from a pilot study on the estrogenic activity of soy formula. J Expo Sci Environ Epidemiol 2009;19:223-34.
93. Yan L, Spitznagel EL. Soy consumption and prostate cancer risk in men: a revisit of a meta-analysis. Am J Clin Nutr 2009;89:1155-63.
94. Yan L, Spitznagel EL. Meta-analysis of soy food and risk of prostate cancer in men. Int J Cancer 2005;117:667-9.
95. Hwang YW, Kim SY, Jee SH, Kim YN, Nam CM. Soy food consump- tion and risk of prostate cancer: a meta-analysis of observational stud- ies. Nutr Cancer 2009;61:598-606.
96. Wu AH, Yu MC, Tseng CC, Pike MC. Epidemiology of soy exposures and breast cancer risk. Br J Cancer 2008;98:9-14.
97. Zhong X, Zhang C. Soy food intake and breast cancer risk: a meta- analysis. Wei Sheng Yan Jiu 2012;41:670-6.
98. Dong JY, Qin LQ. Soy isoflavones consumption and risk of breast can- cer incidence or recurrence: a meta-analysis of prospective studies. Breast Cancer Res Treat 2011;125:315-23.
99. Chen M, Rao Y, Zheng Y, Wei S, Li Y, Guo T, Yin P. Association be- tween soy isoflavone intake and breast cancer risk for pre- and post- menopausal women: a meta-analysis of epidemiological studies. PLoS ONE 2014;9:e89288.
100. Shimizu H, Ross RK, Bernstein L, Yatani R, Henderson BE, Mack TM. Cancers of the prostate and breast among Japanese and white immi- grants in Los Angeles County. Br J Cancer 1991;63:963-6.
101. Polkowski K, Popio1kiewicz J, Krzeczyński P, Ramza J, Pucko W, Zegrocka-Stendel O, Boryski J, Skierski JS, Mazurek AP, Grynkiewicz G, et al. Cytostatic and cytotoxic activity of synthetic genistein glycosides against human cancer cell lines. Cancer Lett 2004;203:59-69.
102. Popio1kiewicz J, Polkowski K, Skierski JS, Mazurek AP. In vitro toxic- ity evaluation in the development of new anticancer drugs-genistein glycosides. Cancer Lett 2005;229:67-75.
103. Michikawa T, Inoue M, Sawada N, Tanaka Y, Yamaji T, Iwasaki M, Shimazu T, Sasazuki S, Mizokami M, Tsugane S. Plasma isoflavones and risk of primary liver cancer in Japanese women and men with hepatitis virus infection: a nested case-control study. Cancer Epide- miol Biomarkers Prev 2015;24:532-7.
104. Gu Y, Zhu CF, Iwamoto H, Chen JS. Genistein inhibits invasive poten- tial of human hepatocellular carcinoma by altering cell cycle, apopto- sis, and angiogenesis. World J Gastroenterol 2005;11:6512-7.
105. Mansoor TA, Ramalho RM, Luo X, Ramalhete C, Rodrigues CM, Ferreira MJ. Isoflavones as apoptosis inducers in human hepatoma HuH-7 cells. Phytother Res 2011;25:1819-24.
106. Yeh TC, Chiang PC, Li TK, Hsu JL, Lin CJ, Wang SW, Peng CY, Guh JH. Genistein induces apoptosis in human hepatocellular carcinomas via interaction of endoplasmic reticulum stress and mitochondrial in- sult. Biochem Pharmacol 2007;73:782-92.
107. Chodon D, Ramamurty N, Sakthisekaran D. Preliminary studies on induction of apoptosis by genistein on HepG2 cell line. Toxicol In Vi- tro 2007;21:887-91.
108. Gu Y, Zhu CF, Dai YL, Zhong Q, Sun B. Inhibitory effects of genistein on metastasis of human hepatocellular carcinoma. World J Gastroen- terol 2009;15:4952-7.
109. Dai W, Wang F, He L, Lin C, Wu S, Chen P, Zhang Y, Shen M, Wu D, Wang C. Genistein inhibits hepatocellular carcinoma cell migration by reversing the epithelial-mesenchymal transition: partial mediation by the transcription factor NFAT. Mol Carcinog 2015;54:301-11.
110. Wang SD, Chen BC, Kao ST, Liu CJ, Yeh CC. Genistein inhibits tumor invasion by suppressing multiple signal transduction pathways in hu- man hepatocellular carcinoma cells. BMC Complement Altern Med 2014;14:26.
111. Jin CY, Park C, Kim GY, Lee SJ, KimWJ, Choi YH. Genistein enhances TRAIL-induced apoptosis through inhibition of p38 MAPK signaling in human hepatocellular carcinoma Hep3B cells. Chem Biol Interact 2009;180:143-50.
112. Jin CY, Park C, Moon SK, Kim GY, Kwon TK, Lee SJ, Kim WJ, Choi YH. Genistein sensitizes human hepatocellular carcinoma cells to TRAIL-mediated apoptosis by enhancing Bid cleavage. Anticancer Drugs 2009;20:713-22.
113. Ma Y, Wang J, Liu L, Zhu H, Chen X, Pan S, Sun X, Jiang H. Genistein potentiates the effect of arsenic trioxide against human hepatocellular carcinoma: role of Akt and nuclear factor-kappa B. Cancer Lett 2011; 301:75-84.
114. Chodon D, Banu SM, Padmavathi R, Sakthisekaran D. Inhibition of cell proliferation and induction of apoptosis by genistein in experi- mental hepatocellular carcinoma. Mol Cell Biochem 2007;297: 73-80.
115. Ko KP, Park SK, Park B, Yang JJ, Cho LY, Kang C, Kim CS, Gwack J, Shin A, Kim Y. Isoflavones from phytoestrogens and gastric cancer risk: a nested case-control study within the Korean Multicenter Can- cer Cohort. Cancer Epidemiol Biomarkers Prev 2010;19:1292-300.
116. Hara A, Sasazuki S, Inoue M, Miura T, Iwasaki M, Sawada N, Shimazu T, Yamaji T, Tsugane S. Plasma isoflavone concentrations are not as- sociated with gastric cancer risk among Japanese men and women. J Nutr 2013;143:1293-8.
117. Zhou HB, Chen JJ, Wang WX, Cai JT, Du Q. Apoptosis of human pri- mary gastric carcinoma cells induced by genistein. World J Gastroen- terol 2004;10:1822-5.
118. Zhou HB, Chen JM, Cai JT, Du Q, Wu CN. Anticancer activity of gen- istein on implanted tumor of human SG7901 cells in nude mice. World J Gastroenterol 2008;14:627-31.
119. Li YS, Wu LP, Li KH, Liu YP, Xiang R, Zhang SB, Zhu LY, Zhang LY. Involvement of nuclear factor kappa B (NF-kappa B) in the downre- gulation of cyclooxygenase-2 (COX-2) by genistein in gastric cancer cells. J Int Med Res 2011;39:2141-50.
120. Liu YL, Zhang GQ, Yang Y, Zhang CY, Fu RX, Yang YM. Genistein in- duces G2/M arrest in gastric cancer cells by increasing the tumor sup- pressor PTEN expression. Nutr Cancer 2013;65:1034-41.
121. Yan GR, Zou FY, Dang BL, Zhang Y, Yu G, Liu X, He QY. Genistein- induced mitotic arrest of gastric cancer cells by downregulating KIF20A: a proteomics study. Proteomics 2012;12:2391-9.
122. Huang W, Wan C, Luo Q, Huang Z. Genistein-inhibited cancer stem cell-like properties and reduced chemoresistance of gastric cancer. Int J Mol Sci 2014;15:3432-43.
123. Yu D, Shin HS, Lee YS, Lee D, Kim S, Lee YC. Genistein attenuates cancer stem cell characteristics in gastric cancer through the downre- gulation of Gli1. Oncol Rep 2014;31:673-8.
124. Tatsuta M, Iishi H, Baba M, Yano H, Uehara H, Nakaizumi A. Atten- uation by genistein of sodium-chloride-enhanced gastric carcinogen- esis induced by N-methyl-N9-nitro-N-nitrosoguanidine inWistar rats. Int J Cancer 1999;80:396-9.
125. Yanagihara K, Takigahira M, Mihara K, Kubo T, Morimoto C, Morita Y, Terawaki K, Uezono Y, Seyama T. Inhibitory effects of isoflavones on tumor growth and cachexia in newly established cachectic mouse models carrying human stomach cancers. Nutr Cancer 2013;65:578-89.
126. Schabath MB, Hernandez LM, Wu X, Pillow PC, Spitz MR. Die- tary phytoestrogens and lung cancer risk. JAMA 2005;294:1493- 504.
127. Seow A, Koh WP, Wang R, Lee HP, Yu MC. Reproductive variables, soy intake, and lung cancer risk among nonsmoking women in the Singapore Chinese Health Study. Cancer Epidemiol Biomarkers Prev 2009;18:821-7.
128. Cutler GJ, Nettleton JA, Ross JA, Harnack LJ, Jacobs DR, Jr., Scrafford CG, Barraj LM, Mink PJ, Robien K. Dietary flavonoid intake and risk of cancer in postmenopausal women: the IowaWomen's Health Study. Int J Cancer 2008;123:664-71.
129. Shimazu T, Inoue M, Sasazuki S, Iwasaki M, Sawada N, Yamaji T, Tsugane S. Isoflavone intake and risk of lung cancer: a prospective cohort study in Japan. Am J Clin Nutr 2010;91:722-8.
130. Shimazu T, Inoue M, Sasazuki S, Iwasaki M, Sawada N, Yamaji T, Tsugane S. Plasma isoflavones and the risk of lung cancer in women: a nested case-control study in Japan. Cancer Epidemiol Biomarkers Prev 2011;20:419-27.
131. Zhu H, Cheng H, Ren Y, Liu ZG, Zhang YF, De Luo B. Synergistic in- hibitory effects by the combination of gefitinib and genistein on NSCLC with acquired drug-resistance in vitro and in vivo. Mol Biol Rep 2012;39:4971-9.
132. Mahmood J, Jelveh S, Calveley V, Zaidi A, Doctrow SR, Hill RP. Mit- igation of radiation-induced lung injury by genistein and EUK-207. Int J Radiat Biol 2011;87:889-901.
133. Gadgeel SM, Ali S, Philip PA, Wozniak A, Sarkar FH. Genistein en- hances the effect of epidermal growth factor receptor tyrosine kinase inhibitors and inhibits nuclear factor kappa B in nonsmall cell lung cancer cell lines. Cancer 2009;115:2165-76.
134. Wu TC, Yang YC, Huang PR, Wen YD, Yeh SL. Genistein enhances the effect of trichostatin A on inhibition of A549 cell growth by increasing expression of TNF receptor-1. Toxicol Appl Pharmacol 2012;262:247-54.
135. Tian T, Li J, Li B, Wang Y, Li M, Ma D, Wang X. Genistein exhibits anti-cancer effects via down-regulating FoxM1 in H446 small-cell lung cancer cells. Tumour Biol 2014;35:4137-45.
136. Shiau RJ, Chen KY, Wen YD, Chuang CH, Yeh SL. Genistein and b-carotene enhance the growth-inhibitory effect of trichostatin A in A549 cells. Eur J Nutr 2010;49:19-25.
137. Peng B, Cao J, Yi S, Wang C, Zheng G, He Z. Inhibition of prolifera- tion and induction of G1-phase cell-cycle arrest by dFMGEN, a novel genistein derivative, in lung carcinoma A549 cells. Drug Chem Toxicol 2013;36:196-204.
138. Messina M, Bennink M. Soyfoods, isoflavones and risk of colonic can- cer: a review of the in vitro and in vivo data. Baillieres Clin Endocrinol Metab 1998;12:707-28.
139. Thiagarajan DG, Bennink MR, Bourquin LD, Kavas FA. Prevention of precancerous colonic lesions in rats by soy flakes, soy flour, genistein, and calcium. Am J Clin Nutr 1998;68:1394S-9S.
140. Spector D, Anthony M, Alexander D, Arab L. Soy consumption and colorectal cancer. Nutr Cancer 2003;47:1-12.
141. Rossi M, Negri E, Talamini R, Bosetti C, Parpinel M, Gnagnarella P, Franceschi S, Dal Maso L, Montella M, Giacosa A, et al. Flavonoids and colorectal cancer in Italy. Cancer Epidemiol Biomarkers Prev 2006;15:1555-8.
142. Cotterchio M, Boucher BA, Manno M, Gallinger S, Okey A, Harper P. Dietary phytoestrogen intake is associated with reduced colorectal cancer risk. J Nutr 2006;136:3046-53.
143. Kim EJ, Shin HK, Park JH. Genistein inhibits insulin-like growth factor-I receptor signaling in HT-29 human colon cancer cells: a pos- sible mechanism of the growth inhibitory effect of Genistein. J Med Food 2005;8:431-8.
144. Su SJ, Chow NH, Kung ML, Hung TC, Chang KL. Effects of soy iso- flavones on apoptosis induction and G2-M arrest in human hepatoma cells involvement of caspase-3 activation, Bcl-2 and Bcl-XL downregu- lation, and Cdc2 kinase activity. Nutr Cancer 2003;45:113-23.
145. Bielecki A, Roberts J, Mehta R, Raju J. Estrogen receptor-beta medi- ates the inhibition of DLD-1 human colon adenocarcinoma cells by soy isoflavones. Nutr Cancer 2011;63:139-50.
146. QiW,Weber CR,Wasland K, Savkovic SD. Genistein inhibits proliferation of colon cancer cells by attenuating a negative effect of epidermal growth factor on tumor suppressor FOXO3 activity. BMC Cancer 2011;11:219.
147. Zhang Y, Chen H. Genistein attenuates WNT signaling by up-regulating sFRP2 in a human colon cancer cell line. Exp Biol Med (Maywood) 2011;236:714-22.
148. Wang H, Li Q, Chen H. Genistein affects histone modifications on Dickkopf-related protein 1 (DKK1) gene in SW480 human colon can- cer cell line. PLoS ONE 2012;7:e40955.
149. Zhang Y, Li Q, Zhou D, Chen H. Genistein, a soya isoflavone, prevents azoxymethane-induced up-regulation of WNT/beta-catenin signalling and reduces colon pre-neoplasia in rats. Br J Nutr 2013;109:33-42.
150. Dai Q, Shu XO, Jin F, Potter JD, Kushi LH, Teas J, Gao YT, Zheng W, et al. Population-based case-control study of soyfood intake and breast cancer risk in Shanghai. Br J Cancer 2001;85:372-8.
151. Wu AH, Yu MC, Tseng CC, Twaddle NC, Doerge DR. Plasma isofla- vone levels versus self-reported soy isoflavone levels in Asian-American women in Los Angeles County. Carcinogenesis 2004;25:77-81.
152. Yamamoto S, Sobue T, Kobayashi M, Sasaki S, Tsugane S. Soy, isofla- vones, and breast cancer risk in Japan. J Natl Cancer Inst 2003;95:906-13.
153. Liu Y, Zhang YM, Song DF, Cui HB. Effect of apoptosis in human breast cancer cells and its probable mechanisms by genistein. Wei Sheng Yan Jiu 2005;34:67-9.
154. Hsieh CY, Santell RC, Haslam SZ, Helferich WG. Estrogenic effects of genistein on the growth of estrogen receptor-positive human breast cancer (MCF-7) cells in vitro and in vivo. Cancer Res 1998;58:3833-8.
155. Satoh H, Nishikawa K, Suzuki K, Asano R, Virgona N, Ichikawa T, Hagiwara K, Yano T. Genistein, a soy isoflavone, enhances necrotic- like cell death in a breast cancer cell treated with a chemotherapeutic agent. Res Commun Mol Pathol Pharmacol 2003;113-114:149-58.
156. Mai Z, Blackburn GL, Zhou JR. Genistein sensitizes inhibitory effect of tamoxifen on the growth of estrogen receptor-positive and HER2-over- expressing human breast cancer cells. Mol Carcinog 2007;46:534-42.
157. Li Y, Ahmed F, Ali S, Philip PA, Kucuk O, Sarkar FH. Inactivation of nuclear factor kappaB by soy isoflavone genistein contributes to in- creased apoptosis induced by chemotherapeutic agents in human can- cer cells. Cancer Res 2005;65:6934-42.
158. Gong L, Li Y, Nedeljkovic-Kurepa A, Sarkar FH. Inactivation of NF- kappaB by genistein is mediated via Akt signaling pathway in breast cancer cells. Oncogene 2003;22:4702-9.
159. Caëtano B, Le Corre L, Chalabi N, Delort L, Bignon YJ, Bernard- Gallon DJ. Soya phytonutrients act on a panel of genes implicated with BRCA1 and BRCA2 oncosuppressors in human breast cell lines. Br J Nutr 2006;95:406-13.
160. Seo HS, DeNardo DG, Jacquot Y, Laios I, Vidal DS, Zambrana CR, Leclercq G, Brown PH. Stimulatory effect of genistein and apigenin on the growth of breast cancer cells correlates with their ability to ac- tivate ER alpha. Breast Cancer Res Treat 2006;99:121-34.
161. Liu B, Edgerton S, Yang X, Kim A, Ordonez-Ercan D, Mason T, Alvar- ez K, McKimmey C, Liu N, Thor A. Low-dose dietary phytoestrogen abrogates tamoxifen-associated mammary tumor prevention. Cancer Res 2005;65:879-86.
162. Lamartiniere CA, Zhang JX, Cotroneo MS. Genistein studies in rats: potential for breast cancer prevention and reproductive and develop- mental toxicity. Am J Clin Nutr 1998;68:1400S-5S.
163. Ju YH, Allred KF, Allred CD, Helferich WG. Genistein stimulates growth of human breast cancer cells in a novel, postmenopausal ani- mal model, with low plasma estradiol concentrations. Carcinogenesis 2006;27:1292-9.
164. Marini H, Bitto A, Altavilla D, Burnett BP, Polito F, Di Stefano V, Minutoli L, Atteritano M, Levy RM, D'Anna R, et al. Breast safety and efficacy of genistein aglycone for postmenopausal bone loss: a follow- up study. J Clin Endocrinol Metab 2008;93:4787-96.
165. Atteritano M, Pernice F, Mazzaferro S, Mantuano S, Frisina A, D'Anna R, Cannata ML, Bitto A, Squadrito F, Frisina N, et al. Effects of phy- toestrogen genistein on cytogenetic biomarkers in postmenopausal women: 1 year randomized, placebo-controlled study. Eur J Pharma- col 2008;589:22-6.
166. McMichael-Phillips DF, Harding C, Morton M, Roberts SA, Howell A, Potten CS, Bundred NJ. Effects of soy-protein supplementation on ep- ithelial proliferation in the histologically normal human breast. Am J Clin Nutr 1998;68(Suppl):1431S-5S.
167. Hargreaves DF, Potten CS, Harding C, Shaw LE, Morton MS, Roberts SA, Howell A, Bundred NJ. Two-week dietary soy supplementation has an estrogenic effect on normal premenopausal breast. J Clin En- docrinol Metab 1999;84:4017-24.
168. Khan SA, Chatterton RT, Michel N, Bryk M, Lee O, Ivancic D, Heinz R, Zalles CM, Helenowski IB, Jovanovic BD, et al. Soy isoflavone sup- plementation for breast cancer risk reduction: a randomized phase II trial. Cancer Prev Res (Phila) 2012;5:309-19.
169. [cited 2014 Nov 13]. Available from: www.clinicaltrials.gov.
170. Nguyen DT, Hernandez-Montes E, Vauzour D, Schönthal AH, Rice- Evans C, Cadenas E, Spencer JP. The intracellular genistein metabolite 5,7,39,49-tetrahydroxyisoflavone mediates G2-M cell cycle arrest in cancer cells via modulation of the p38 signaling pathway. Free Radic Biol Med 2006;41:1225-39.
171. Kiriakidis S, Högemeier O, Starcke S, Dombrowski F, Hahne JC, Pepper M, Jha HC, Wernert N. Novel tempeh (fermented soyabean) isoflavones inhibit in vivo angiogenesis in the chicken chorioallantoic membrane assay. Br J Nutr 2005;93:317-23.
172. Vauzour D, Vafeiadou K, Rice-Evans C, Cadenas E, Spencer JP. Inhi- bition of cellular proliferation by the genistein metabolite 5,7,39,49- tetrahydroxyisoflavone is mediated by DNA damage and activation of the ATR signalling pathway. Arch Biochem Biophys 2007;468: 159-66.
173. Russo M, Spagnuolo C, Tedesco I, Russo GL. Phytochemicals in cancer prevention and therapy: truth or dare? Toxins 2010;2:517- 51. [cited 2014 Nov 13]. Available from: http://www.clinicaltrials.gov.
174. Chang EC, Charn TH, Park SH, Helferich WG, Komm B, Katzenellenbogen JA, Katzenellenbogen BS. Estrogen receptors alpha and beta as determinants of gene expression: influence of ligand, dose, and chromatin binding. Mol Endocrinol 2008; 22:1032-43.